Management of toxic epidermal necrolysis

Hospital Medicine

Volumn 61, Issue 11, 2000, Pages 778-781

  Craven, Nicholas M ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ENTERIC FEEDING; FLUID THERAPY; HUMAN; PROGNOSIS; REVIEW; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ANTI-INFLAMMATORY AGENTS; ENTERAL NUTRITION; EPIDERMAL NECROLYSIS, TOXIC; FLUID THERAPY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; PROGNOSIS; STEROIDS; STEVENS-JOHNSON SYNDROME;

EID: 0034327495     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2000.61.11.1463     Document Type: Article

References (24)

1. Arévalo JM. Lorcntc JA. (Jonzâlez-Herrada C. JimcnezRcyes .1 (2000) Treatment of toxic epidermal nccrolysis with cvclosporin A. J Trauma 48: 473-8
2. Assier I). Bastuji-Garin S, Revuz J. Roujeau JC (1995) lirythema multiforme vvilh mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dcrnuilol 131: 539-43
3. Bastuji-darin S, Rzany B. Stern RS. Shear NH. Naldi L. Roujeau JC (1993) Clinical classification of cases of toxicepidermal necrolysis. Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 129: 92-6
4. Egan CA. Grant WJ. Morris SE, Saffle JR. Zone JJ (1999) Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol 40: 458-61
5. Fischer PR, Shigeoka AO (1983) Familial occurrence of Stevens-Johnson syndrome. Am.J Dis Child 137: 914-6
6. Friedmann PS. Strickland I, Pirmohamed M, Park BK (1994) Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazcpine. Arch Dcrmatol 130: 598-604
7. Garcia-Doval I. LeCleach L, Bocquet H, Otero X-L. Roujcau J-C (2000) Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136: 323-7
8. Guibal F. Bastuji-Garin S, Chosidow O, Saiag P, Revuz J. Roujeau J-C" (1995) Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dcrmatol 131: 669-72
9. Halebian PH. Corder VJ, Madden MR, Finklestein JL. Shires GT (1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without eorticosleroids. Ann Surg 205: 503-12
10. Heng MCY. Alien SG ( 1991 ) Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dcrmatol 25: 778-86
11. Eebargy F. Wolkenstein P, Gisselbrecht M et al (1997) Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 23: 1237-44
12. Martinez AI;, Atherton D.l (2000) High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatr Dermatol 17: 87-90
13. Rasmussen JE (1976) Erythema multiforme in children. Response to treatment with systemic corticosteroids. Br J Dermatol 95: 181-6
14. Revuz R, Roujeau J-C. Guillaume J-C. Penso D. Touraine R (1987) Treatment of toxic epidermal necrolysis. Arch Dcrmatol 123: 1156-8
15. Roujeau J-C, Chosidow O, Saiag P, Guillaume J-C (1990) Toxic epidermal necrolysis (Eyell syndrome). J Am Acad Dermatol 23: 1039-58
16. Roujeau JC, Kelly JP, Xaldi E et al (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333: 1600-7
17. Roujeau J-C, Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Engt J Med 331: 1272-85
18. Saiag P. Caumes E, Chosidow O, Revuz J, Roujeau J-C (1992) Drug-induced toxic epidermal necrolysis (Eyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dcrmatol 26: 567-74
19. Stables Gl, Eever RS ( 1993) Toxic epidermal necrolysis and systemic corticosteroids. Br J Dermatol 128: 357
20. Tagami H. Tatsuta K. Iwatski K, Yamada M (1983) Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Arch Dermatol 119: 910-3
21. Tripathi A. Ditto AM, Grammer LC et al (2000) Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases. Allergv and Asthma'Pmc 21: 101-5
22. Viard l.'Wehrli P Bullani R et al (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282: 490-3
23. Villada G. Roujeau J-C. Cordonnier C et al ( 1990) Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. J Am Acad Dcrmatol 23: 870-5
24. Wolkenstein P, Eatarjet J. Roujeau J-C et al (1998) Randomised comparison of thalidomidc versus placebo in toxic epidermal necrolvsis. Lancet 352: 1586-9